Maternal obesity increases offspring's mammary cancer recurrence and impairs tumor immune response. Issue 9 (September 2020)
- Record Type:
- Journal Article
- Title:
- Maternal obesity increases offspring's mammary cancer recurrence and impairs tumor immune response. Issue 9 (September 2020)
- Main Title:
- Maternal obesity increases offspring's mammary cancer recurrence and impairs tumor immune response
- Authors:
- Zhang, Xiyuan
de Oliveira Andrade, Fabia
Zhang, Hansheng
Cruz, Idalia
Clarke, Robert
Gaur, Pankaj
Verma, Vivek
Hilakivi-Clarke, Leena - Abstract:
- Abstract : Over 50% of women at a childbearing age in the United States are overweight or obese, and this can adversely affect their offspring. We studied if maternal obesity-inducing high fat diet (HFD) not only increases offspring's mammary cancer risk but also impairs response to antiestrogen tamoxifen. Female rat offspring of HFD and control diet-fed dams, in which estrogen receptor-positive (ER+) mammary tumors were induced with the carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA), exhibited similar initial responses to antiestrogen tamoxifen. However, after tamoxifen therapy was completed, almost all (91%) tumors recurred in HFD offspring, compared with only 29% in control offspring. The increase in local mammary tumor recurrence in HFD offspring was linked to an increase in the markers of immunosuppression ( Il17f, Tgfβ1, VEGFR2) in the tumor microenvironment (TME). Protein and mRNA levels of the major histocompatibility complex II (MHC-II), but not MHC-I, were reduced in the recurring DMBA tumors of HFD offspring. Further, infiltration of CD8 + effector T cells and granzyme B+ (GZMB+) cells were lower in their recurring tumors. To determine if maternal HFD can pre-program similar changes in the TME of allografted E0771 mammary tumors in offspring of syngeneic mice, flow cytometry analysis was performed. E0771 mammary tumor growth was significantly accelerated in the HFD offspring, and a reduction in the numbers of GZMB and non-significant reduction of interferon γAbstract : Over 50% of women at a childbearing age in the United States are overweight or obese, and this can adversely affect their offspring. We studied if maternal obesity-inducing high fat diet (HFD) not only increases offspring's mammary cancer risk but also impairs response to antiestrogen tamoxifen. Female rat offspring of HFD and control diet-fed dams, in which estrogen receptor-positive (ER+) mammary tumors were induced with the carcinogen 7, 12-dimethylbenz[a]anthracene (DMBA), exhibited similar initial responses to antiestrogen tamoxifen. However, after tamoxifen therapy was completed, almost all (91%) tumors recurred in HFD offspring, compared with only 29% in control offspring. The increase in local mammary tumor recurrence in HFD offspring was linked to an increase in the markers of immunosuppression ( Il17f, Tgfβ1, VEGFR2) in the tumor microenvironment (TME). Protein and mRNA levels of the major histocompatibility complex II (MHC-II), but not MHC-I, were reduced in the recurring DMBA tumors of HFD offspring. Further, infiltration of CD8 + effector T cells and granzyme B+ (GZMB+) cells were lower in their recurring tumors. To determine if maternal HFD can pre-program similar changes in the TME of allografted E0771 mammary tumors in offspring of syngeneic mice, flow cytometry analysis was performed. E0771 mammary tumor growth was significantly accelerated in the HFD offspring, and a reduction in the numbers of GZMB and non-significant reduction of interferon γ (IFNγ) secreting CD8 + T cells in the TME was seen. Thus, consumption of a HFD during pregnancy increases susceptibility of the female rat and mouse offspring to tumor immune suppression and mammary tumor growth and recurrence. … (more)
- Is Part Of:
- Endocrine-related cancer. Volume 27:Issue 9(2020)
- Journal:
- Endocrine-related cancer
- Issue:
- Volume 27:Issue 9(2020)
- Issue Display:
- Volume 27, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 27
- Issue:
- 9
- Issue Sort Value:
- 2020-0027-0009-0000
- Page Start:
- 469
- Page End:
- 482
- Publication Date:
- 2020-09
- Subjects:
- breast cancer -- tamoxifen therapy -- local recurrence -- inflammation -- tumor immune microenvironment
Endocrine glands -- Cancer -- Periodicals
Endocrinology -- Periodicals
Cancer -- Endocrine aspects -- Periodicals
616.9944005 - Journal URLs:
- http://www.bioscientifica.com/ ↗
http://erc.endocrinology-journals.org/ ↗ - DOI:
- 10.1530/ERC-20-0065 ↗
- Languages:
- English
- ISSNs:
- 1351-0088
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15541.xml